全球生物分析檢測服務市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計生物分析測試服務市場將從 2025 年的 51.6 億美元成長到 2034 年的 112.7 億美元，2026 年至 2034 年的複合年成長率為 9.07%。

隨著製藥和生技公司不斷擴大研發活動，全球生物分析檢測服務市場正經歷顯著成長。這些服務在藥物研發過程中至關重要，因為它們能夠分析生物樣本，評估藥物濃度、代謝和安全性。隨著複雜生物製藥和先進治療方法的研發不斷推進，製藥公司越來越依賴專業的檢測服務，以確保符合監管要求並維持藥物研發的效率。

推動市場發展的關鍵因素之一是將檢測服務外包給合約研究組織（CRO）的趨勢日益成長。製藥公司之所以傾向於外包，是因為這可以降低營運成本，使他們能夠專注於核心研發活動。此外，全球臨床試驗數量的不斷增加也催生了對生物分析檢測的強勁需求。分析儀器的技術進步，包括質譜和層析法，也不斷提高生物檢體分析的準確性和速度。

隨著個人化醫療和生物製藥的日益普及，生物分析檢測服務市場預計將進一步成長。日益嚴格的藥品安全監管也將需要更精細的檢測和驗證流程。隨著全球藥物研發活動的擴張，新興市場有望在未來的市場成長中發揮重要作用。分析技術的持續創新將進一步推動市場發展，並有助於提升檢測能力。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球生物分析檢測服務市場：依分子類型分類

• 市場分析、洞察與預測
• 低分子
• 聚合物化合物

第5章 全球生物分析檢測服務市場：依檢測類型分類

• 市場分析、洞察與預測
• DMPK 測試
• 生物標記檢測
• 病毒檢測
• 體內病毒學檢測
• 體外病毒學
• 血清學檢測
• 免疫抗原性試驗
• 其他測試類型

第6章 全球生物分析檢測服務市場：依應用分類

• 市場分析、洞察與預測
• 腫瘤學
• 神經病學
• 感染疾病
• 胃腸病學
• 循環系統
• 其他用途

第7章 全球生物分析檢測服務市場：依最終用途分類

• 市場分析、洞察與預測
• 製藥和生物技術公司
• 受託研究機構
• 研究和學術機構
• 其他最終用戶

第8章 全球生物分析檢測服務市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • BioAgilytix
  • Charles River Laboratories Inc
  • Eurofins Scientific
  • Frontage Labs
  • ICON Plc
  • Intertek Group Plc
  • Labcorp Drug Development
  • Pace Analytical Services LLC
  • SGS SociAfA（C）TAfA（C）GAfA（C）NAfA（C）Rale De Surveillance SA
  • Syneos Health
  • Thermo Fisher Scientific Inc
  • WuXi AppTec

The Bioanalytical Testing Services Market size is expected to reach USD 11.27 Billion in 2034 from USD 5.16 Billion (2025) growing at a CAGR of 9.07% during 2026-2034.

The global bioanalytical testing services market is witnessing significant growth as pharmaceutical and biotechnology companies continue to increase research and development activities. These services are essential in drug development because they analyze biological samples to evaluate drug concentration, metabolism, and safety. As the development of complex biologics and advanced therapies increases, pharmaceutical companies are relying heavily on specialized testing services to ensure compliance with regulatory requirements and maintain drug development efficiency.

One of the key drivers of the market is the rising trend of outsourcing testing services to contract research organizations. Pharmaceutical companies prefer outsourcing because it reduces operational costs and allows them to focus on core research activities. Additionally, the increasing number of clinical trials worldwide is creating strong demand for bioanalytical testing. Technological advancements in analytical instruments, including mass spectrometry and chromatography, are also improving the precision and speed of biological sample analysis.

Looking ahead, the bioanalytical testing services market is expected to grow further as personalized medicine and biologic therapies become more common. Increasing regulatory scrutiny regarding drug safety will also require more detailed testing and validation processes. Emerging markets are expected to play an important role in future expansion as pharmaceutical research activities grow globally. Continuous innovation in analytical technologies will further support market development and improve testing capabilities.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Molecule Type

• Small Molecule
• Large Molecule

By Test Type

• Dmpk Testing
• Biomarker Testing
• Virology Testing
• In-Vivo Virology Testing
• In-Vitro Virology Testing
• Serology Testing
• Immunogenicity Testing
• Other Test Types

By Application

• Oncology
• Neurology
• Infectious Diseases
• Gastroenterology
• Cardiology
• Other Applications

By End-Use

• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations
• Research & Academic Institutes
• Other End-Users

COMPANIES PROFILED

• BioAgilytix, Charles River Laboratories Inc, Eurofins Scientific, Frontage Labs, ICON Plc, Intertek Group Plc, Labcorp Drug Development, Pace Analytical Services LLC, SGS Socit Gnrale de Surveillance SA, Syneos Health, Thermo Fisher Scientific Inc, WuXi AppTec
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET: BY MOLECULE TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Molecule Type
• 4.2. Small Molecule Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Large Molecule Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET: BY TEST TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Test Type
• 5.2. Dmpk Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Biomarker Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Virology Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. In-Vivo Virology Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. In-Vitro Virology Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Serology Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Immunogenicity Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.9. Other Test Types Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Neurology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Infectious Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Gastroenterology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Cardiology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET: BY END-USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-use
• 7.2. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Contract Research Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Research & Academic Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Other End-Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Molecule Type
  • 8.2.2 By Test Type
  • 8.2.3 By Application
  • 8.2.4 By End-use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Molecule Type
  • 8.3.2 By Test Type
  • 8.3.3 By Application
  • 8.3.4 By End-use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Molecule Type
  • 8.4.2 By Test Type
  • 8.4.3 By Application
  • 8.4.4 By End-use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Molecule Type
  • 8.5.2 By Test Type
  • 8.5.3 By Application
  • 8.5.4 By End-use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Molecule Type
  • 8.6.2 By Test Type
  • 8.6.3 By Application
  • 8.6.4 By End-use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL BIOANALYTICAL TESTING SERVICES INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 BioAgilytix
  • 10.2.2 Charles River Laboratories Inc
  • 10.2.3 Eurofins Scientific
  • 10.2.4 Frontage Labs
  • 10.2.5 ICON Plc
  • 10.2.6 Intertek Group Plc
  • 10.2.7 Labcorp Drug Development
  • 10.2.8 Pace Analytical Services LLC
  • 10.2.9 SGS SociAfA(C)TAfA(C) GAfA(C)NAfA(C)Rale De Surveillance SA
  • 10.2.10 Syneos Health
  • 10.2.11 Thermo Fisher Scientific Inc
  • 10.2.12 WuXi AppTec